Revolution Medicines, Inc. <RVMD.O>: Needham raises target price to $275 from $240
RVMD•Related News
NetSol names Faizaan Ghauri president of Americas unit
NTWK•
Sabra Health Care REIT, Inc. <SBRA.O>: Mizuho raises target price to $21 from $20
SBRA•
A-6684 reports purchase of 5,000 Tofutti Brands common shares worth $2,250
TOFB•
TELA Bio COO and CFO Roberto Cuca steps down
TELA•
Eli Lilly to buy Merida Biosciences in $2.88 billion deal
LLY•